What to Expect in Your First 90 Days The early months of GLP-1 therapy set the tone for success
Looking ahead, beverages are expected to play an increasingly central role as some GLP-1 users consume fewer solid foods, Colindres continues
While results vary by patients, a survey conducted by AlphaWise and Morgan Stanley suggests that the average patient reduces their calorie intake by 2030% and eats 2040% fewer meals and snacks
Novo Nordisk sued Hims & Hers on Feb
For instance, in January 2025, Nacuity Pharmaceuticals, Inc., was presented with the Fast Track designation for NPI-001 (N-acetylcysteine amide) tablets from the U.S
This approach complements, rather than replaces, head-to-head trial data, and is particularly useful in contexts where direct evidence is lacking